These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7846203)

  • 1. Flumazenil has an anxiolytic effect in simulated stress.
    Kapczinski F; Curran HV; Gray J; Lader M
    Psychopharmacology (Berl); 1994 Feb; 114(1):187-9. PubMed ID: 7846203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties.
    Sliva J; Hess L; Votava M; Malek J
    Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated public speaking as a model of clinical anxiety.
    McNair DM; Frankenthaler LM; Czerlinsky T; White TW; Sasson S; Fisher S
    Psychopharmacology (Berl); 1982; 77(1):7-10. PubMed ID: 6126900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.
    File SE; Hitchcott PK
    Psychopharmacology (Berl); 1990; 101(4):525-32. PubMed ID: 1975108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil.
    Curran HV; Birch B
    Psychopharmacology (Berl); 1991; 103(4):519-23. PubMed ID: 1676530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of flumazenil, Ro 15-4513 and beta-CCM on the behaviour of control and stressed mice in the plus-maze test.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1997 Jun; 48(2):253-61. PubMed ID: 9223029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumazenil blockade of anxiety following ethanol withdrawal in rats.
    Moy SS; Knapp DJ; Criswell HE; Breese GR
    Psychopharmacology (Berl); 1997 Jun; 131(4):354-60. PubMed ID: 9226737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flumazenil blocks the anxiolytic action of allopregnanolone.
    Fernández-Guasti A; Picazo O
    Eur J Pharmacol; 1995 Jul; 281(1):113-5. PubMed ID: 8566110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
    Nutt DJ; Glue P; Lawson C; Wilson S
    Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
    Chopin P; Briley M
    Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of Bifidobacterium adolescentis IM38 in mice with or without immobilisation stress.
    Jang HM; Jang SE; Han MJ; Kim DH
    Benef Microbes; 2018 Jan; 9(1):123-132. PubMed ID: 28969445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anxiolytic action of phenoxypropanolamine derivatives in comparison with propranolol, diazepam and placebo].
    Puttkammer M; Gaertner HJ; Mahal A; May J; Binz U; Heimann H
    Arzneimittelforschung; 1987 Jun; 37(6):721-5. PubMed ID: 2889457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole.
    Dawson GR; Curnow R; Bayley P; Rambridge A; Tricklebank MD
    Eur J Pharmacol; 1994 Feb; 252(3):325-8. PubMed ID: 7909294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.
    Woods SW; Charney DS; Silver JM; Krystal JH; Heninger GR
    Psychiatry Res; 1991 Feb; 36(2):115-27. PubMed ID: 1850142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing.
    Scaife JC; Hou RH; Samuels ER; Baqui F; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2007 Jan; 21(1):93-101. PubMed ID: 16533870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
    Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV
    Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.